PF-06700841, a Dual TYK2 and JAK1 Inhibitor for the Treatment of Autoimmune Diseases
Autoimmune diseases are condition arising from an abnormal immune response to a normal body part. Autoimmune diseases are generally characterized by a dysregulation of cytokine signaling. Cytokine signaling is an…